About

About
The DS management team has both a strong background in developing drugs for the market and experience in building life science companies.

Pipeline

Pipeline
DS Biopharma have three novel assets in various stages of clinical and pre-clinical development and intend to add more bioactive lipids to the current portfolio in the coming years.

Investors

Investors
To date, DS Biopharma have been funded privately.

Latest News

September 15, 2016

DS Biopharma announces the appointment of Dr. Markus Weissbach as Chief Operating Officer

Dublin, Ireland, 14th September 2016: DS Biopharma (DS) today announced the appointment of Dr. Markus Weissbach (MD, PhD) to Chief Operating Officer. Markus has been Medical […]
August 23, 2016

DS Biopharma (DS) Announces Spin-Out Company Focused on Fibrotic Conditions and Pulmonary Disorders

Dublin, Ireland, 22 August 2016: DS Biopharma (DS), a privately held drug discovery and development company with industry-leading expertise in lipid science, today announces the launch […]

Join our mailing list

Connect with us